1. Department of Clinical Science; Targovax Oy; Helsinki Finland
2. Department of Virology; National Institute of Public Health-National Institute of Hygiene; Warsaw Poland
3. Drug Research Program; ImmunoVirothearpy Lab, Faculty of Pharmacy, University of Helsinki; Helsinki Finland
4. Department of Clinical Science; Targovax ASA; Oslo Norway
5. Catalan Institute of Oncology; IDIBELL; Barcelona Spain